Zusammenfassung
Erste Zusammenhänge von Herzbeteiligungen und entzündlich-rheumatischen Erkrankungen wurden schon Ende des 19. Jahrhunderts beschrieben, wobei seither Myoperikarditiden und Endokarditiden am häufigsten dokumentiert wurden. Entzündlich-rheumatische Erkrankungen können teils mit unterschiedlicher Häufigkeit zu einer Herzbeteiligung mit erhöhter kardiovaskulärer Mortalität führen bei derzeit nicht bekannten Ursachen.
Ziel dieser Übersichtsarbeit ist eine Darstellung möglicher kardiovaskulärer Symptome bei unterschiedlichen entzündlich-rheumatischen Krankheitsbilder für eine effiziente differentialdiagnostische Einordnung und Abklärung im rheumatologischen Praxisalltag.
Summary
First descriptions about cardiovascular manifestations (mostly myocarditis and endocarditis) in inflammatory rheumatic diseases were dated at the end of the 19th century. Inflammatory rheumatic diseases show an increased cardiovascular manifestation and mortality, but the reasons for this are unknown. This overview presents the current knowledge about cardiovascular manifestations in different inflammatory rheumatic diseases for an efficient differential diagnostic and clarification in the daily practice.
References
Al-Herz A, Ensworth S, Shojana K, Esdaile JM (2003) Cardiovascular disease risk factor screening in systemic lupus erythematosus. J Rheumatol 30:493–496
Anavari A, Graninger W, Schneider B et al (1992) Cardiac involvement in systemic sclerosis. Arthritis Rheum 35:1356–1361
Bergfeldt L (1997) HLA-B27-associated cardiac disease. Ann Intern Med 127(8 Pt 1):621–629
Bonfiglio T, Atwater EC (1969) Heart Disease in patients with seropositive rheumatoid arthritis. Arch Intern Med 124:714–719
Bulkley BH, Roberts WC (1973) Ankylosing spondylitis and aortic regurgitation. Description of characteristic cardiovascular lesions from study of eight necropsy patients. Circulation 48(5):1014–1027
Charles EW, Barron T, Lowrimore G et al (1985) Cardiac Sarcoidosis: Two Cases with Ventricular Tachycardia and Review of Cardiac Involvement in Sarcoid. Texas Heart J 12:377–383
Clarke R, Daly L, Robinson K et al (1991) Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 324:1149–1155
Crawford MH, Sergent J (1998) Cardiopulmonary symptoms in rheumatic disease. In: Klippel HJ, Dieppe PA (Hrsg) Rheumatology. Second edition, Vol. 1. Mosby International, London, England 2:7.1–7.8
Delgado AJ, Ames PR, Donohue S et al (2002) Antibodies to high-density lipoprotein and beta-2-glykoprotein I are inversely correlated with paraxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 46:2686–2694
Genth E (2001) Arthritis psoriatica und Arthritiden bei gastrointestinalen Erkrankungen. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, Springer, Berlin Heidelberg, Kapitel 44, S 662–673
Ghosh P, Fleming GA, Stovin PGI (1972) Myocardial sarcoidosis. Br Heart J 34:769–773
Haagsma CJ, Blom HJ, van Riel PLCM et al (1999) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79–84
Hellemanns S, Dens J, Knockaert D (1997) Coronary involvement in the Churg-Strauss syndrome. Heart 77:567–578
Henke R, Allouch V, Häntzschel H (1992) Herzbeteiligung. In: Häntzschel H, Otto W, Nassonova V (Hrsg) Rheumatoid-Arthritis—eine systemische Erkrankung. JA Barth, Leipzig, S 150–153
Herzer P (2000) Lyme-Borreliose. In: Miehle W, Fehr K, Schattenkirchner M, Tillmann K (Hrsg) Rheumatologie in Praxis und Klinik. Thieme, Stuttgart New York, S 742–751
Jung O, Stapfer G, Ditting T, Geiger H, Lange U (2004) Pathologic alterations of the heart and the kidney in patients with ankylosing Spondylitis. Clin Exp Rheumatol 22:666
Kabakov AE, Tertov VV, Saenko VA et al (1992) The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Clin Immunol Immunpathol 63:214–220
Kahl LE (1992) The spectrum of pericardial tamponade in systemic lupus erythematosus: Report of ten patients. Arthritis Rheum 35:1343–349
Kato H, Sugimura T, Akagi T et al (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385
Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Aerugi 16:178–222
Khamashta MA, Cervera R, Asherson RA et al (1990) Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 335:1541–1544
Khan MA (1998) Ankylosing Spondylitis: clinical features. In: Klippel JH, Dieppe PA (eds) Rheumatology, 2nd edition, pp 6.16.1–6.16.10
Lange U, Teichmann J (2003) Whipple arthritis: diagnosis by molecular analysis of synovial fluid—current status of diagnosis and therapy. Rheumatology 42:473–480
Lautermann D (2002) Kardiovaskuläre Manifestationen bei Spondylitis ankylosans. In: Braun J, Sieper J (Hrsg) Spondylitis ankylosans. Uni-Med, Bremen, London, Boston, S 130–135
Lehman TJA, Palmeri ST, Hastings C, Klippel JH et al (1983) Bacterial endocarditis complicating systemic lupus erythematosus. J Rheum 10:655–658
Lethinen K (1980) Cause of death in 79 patients with ankylosing spondylitis. Scand J Rheumatol 9(3):145–147
Liebscher KM, Weise R, Henßge R et al (1986) Herzbeteiligung bei Rheumatoid-Arthritis. Zsch ges inn Med 41:634–636
Liuzzo G, Goronzy JJ, Yang H et al (2000) Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 102:2883–2888
Logar D, Kveder T, Rozman B, Dobovisek J (1990) Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 49:627–629
Märker-Hermann E, Mayet WJ (2001) Organsymptome. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, Springer, Berlin Heidelberg, Kapitel 19, S 266–280
Manger K, Kusus M, Forster C, Ropers D, Daniel WG, Kalden JR, Achenbach S, Manger B (2003) Factors associated with coronary artery calcification in young female patients with SLE. Ann Rheum Dis 62:846–850
Manzi S, Meilahn EN, Rairie JE et al (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145:408–415
Mikuls TR, Saag KG (2001) Comorbidity in rheumatoid arthritis. In: O’Dell JR (ed) Rheumatoid Arthritis. Rheumatic Disease Clinics of North America, Vol. 27, No. 2. WB Saunders, pp 283–297
Niksic F, Burmucic K, Kullich W, Klein G (2002) Kardiovaskuläre Manifestationen bei entzündlich rheumatischen Erkrankungen. Wien Med Wschr 152:220–222
Pasceri V, Yeh ETH (1999) A tale of two diseases—atherosclerosis and rheumatoid arthritis. Circulation 100:2124–2130
Porter GH (1951) Sarcoid heart disease. N Engl J Med 26:1350–1357
Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive Protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843
Roldan CA, Shively BK, Crawford MH (1996) An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 335:1424–1430
Saravana S, Gillott T (2004) Ischaemic heart disease in rheumatoid arthritis patients. Rheumatology, 43:113–114
Schmidt KL (2000) Checkliste Rheumatologie. Thieme, Stuttgart New York
Sukenik S, Pras A, Buskila D et al (1987) Cardiovascular manifestations of ankylosing spondylitis. Clin Rheumatol 6(4):588–592
Torzewski M, Torzewski J, Bowyer DE et al (1998) C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18:1386–1392
Turesson C, Jacobsson S, Berström U (1999) Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology 38:668–674
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lange, U., Strunk, J. Kardiovaskuläre Manifestationen bei entzündlich-rheumatischen Erkrankungen. Z. Rheumatol. 64, 12–17 (2005). https://doi.org/10.1007/s00393-005-0699-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00393-005-0699-3